Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 9-AMINO-1,2,3,4-TETRAHYDRO-ACRIDIN-1-OL, MALEATE

9-AMINO-1,2,3,4-TETRAHYDRO-ACRIDIN-1-OL, MALEATE

9-AMINO-1,2,3,4-TETRAHYDRO-ACRIDIN-1-OL, MALEATE structure

9-AMINO-1,2,3,4-TETRAHYDRO-ACRIDIN-1-OL, MALEATE 

structure
  • CAS No:

    118909-22-1

  • Formula:

    C17H18N2O5

  • Chemical Name:

    9-AMINO-1,2,3,4-TETRAHYDRO-ACRIDIN-1-OL, MALEATE

  • Synonyms:

    HP-029;HYDROXYTACRINE MALEATE;HYDROXYTACRINE MALEATE SALT;9-AMINO-1,2,3,4-TETRAHYDRO-ACRIDINE-1-(2H)-OL MALEATE;9-AMINO-1,2,3,4-TETRAHYDRO-ACRIDIN-1-OL, MALEATE;(±)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol, HP-029;Velnacrine maleate;Velnacrine maleate [usan]

9-AMINO-1,2,3,4-TETRAHYDRO-ACRIDIN-1-OL, MALEATE Basic Attributes

330.34

330.121582

WR9885GALS|4401EF6U24

DTXSID7045158

Pale Beige to Beige

2933998090

Characteristics

133.74000

2.47970

171-173

-20°C Freezer

LD50 in mice (mg/kg): 136 orally; 162 i.p. (Shutske 1988, 1989)

Sealed in dry,2-8°C

Safety Information

T

T

Toxic

Store in freezer at -20°C

Drug Information

Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)

1,2,3,4-tetrahydro-9-aminoacridin-1-ol maleate

9-AMINO-1,2,3,4-TETRAHYDRO-ACRIDIN-1-OL, MALEATE Use and Manufacturing

A potential Alzheimer's Disease therapeutic of low toxicity. Exhibits biochemical and pharmacological profile similar to THA except that it is far less toxic and withoutmeasurable liver toxicity in humans.


Cholinesterase inhibitor. Potential Alzheimer's disease therapeutic

Computed Properties

Molecular Weight:330.33
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:2
Exact Mass:330.12157168
Monoisotopic Mass:330.12157168
Topological Polar Surface Area:134
Heavy Atom Count:24
Complexity:377
Undefined Atom Stereocenter Count:1
Defined Bond Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.